Search results
GRIT and Quangang announce IL-2 T-cell therapy partnership
Pharmaceutical Technology via Yahoo Finance· 1 day agoQuanqi (125SER) is a marketed human Interleukin-2 used in treating solid tumours including renal ...
Galvanize Therapeutics' endoscopic, pulsed-field needle scores FDA clearance in cancer, soft tissue...
FierceBiotech· 7 days agoNow, Galvanize Therapeutics is jumping in with its system...commercial product to combine pulsed...
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R)...
Digital Journal· 24 hours agoAt a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk of distant metastasis ...
GRIT and Quangang Forge Strategic Partnership to Accelerate Localization of Interleukin-2
The Pilot News· 4 days agoCo., Ltd. (GRIT) and Shandong Quangang Pharmaceutical Co., Ltd. (Quangang) announced the establishment of a formal strategic partnership to leverage both parties' R&D capabilities in innovative ...
Merck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Benzinga via Yahoo Finance· 7 days agoTuesday, Merck & Co Inc (NYSE:MRK) released topline data from hase 3 KEYNOTE-522 trial of Keytruda...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 4 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
New Study Finds Increased Disparities in Cancer Su | Newswise
Newswise· 3 days agoFirst approved by the U.S. Food and Drug Administration (FDA) in 2011, ICIs improved survival among...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days ago(the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune ...
Better Prediction of Bladder Cancer Treatment Outcomes
MedPage Today· 5 days agoA study in the Journal of Precision Oncology indicates that MIR145 core promoter methylation in...
New foundation formed to honor Rocky graduate
WHBF Davenport via Yahoo News· 20 hours agoTrue to a Rock Island High School alum who was passionate about his community, a new fundraiser is being introduced in honor of DayQwon (DQ) Jones – a...
